Susquehanna International Group’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-960
Closed -$22.8K 12188
2024
Q2
$22.8K Sell
960
-895
-48% -$25.4K ﹤0.01% 11636
2024
Q1
$56.8K Buy
+1,855
New +$70.3K ﹤0.01% 11511
2023
Q1
Sell
-3,805
Closed -$326K 12723
2022
Q4
$326K Sell
3,805
-310
-8% -$27.9K ﹤0.01% 8891
2022
Q3
$381K Buy
4,115
+3,045
+285% +$327K ﹤0.01% 9175
2022
Q2
$131K Buy
1,070
+100
+10% +$11.7K ﹤0.01% 11194
2022
Q1
$113K Buy
970
+105
+12% +$17.4K ﹤0.01% 11815
2021
Q4
$224K Buy
865
+70
+9% +$21.3K ﹤0.01% 11207
2021
Q3
$217K Sell
795
-1,485
-65% -$428K ﹤0.01% 11305
2021
Q2
$974K Buy
+2,280
New +$868K ﹤0.01% 7845

Other funds holding DRIO

Susquehanna International Group's DRIO Position: Q1 2025 in Review

Susquehanna International Group sold out of DarioHealth (DRIO) in Q1 2025, closing a stake of 1,088 shares — an estimated $17.1K sold.

Susquehanna International Group first reported a position in DRIO in Q4 2017 and held it in 18 quarters. The position peaked at $866K in Q3 2021. 42 funds tracked by Wall St. Rank hold DRIO as of Q1 2025.

  • Susquehanna International Group reported no remaining DarioHealth position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 1,088 DarioHealth shares in Q1 2025, an estimated $17.1K.
  • Susquehanna International Group first reported a position in DarioHealth in Q4 2017 and held it in 18 quarters.
  • Susquehanna International Group's DarioHealth position peaked at $866K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held DarioHealth as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.